Literature DB >> 7774628

Regulation of T cell receptor (TCR)-beta locus allelic exclusion and initiation of TCR-alpha locus rearrangement in immature thymocytes by signaling through the CD3 complex.

C N Levelt1, B Wang, A Ehrfeld, C Terhorst, K Eichmann.   

Abstract

During thymocyte differentiation, the T cell receptor (TCR)-beta genes are rearranged before the TCR-alpha genes. Immature CD4-8- double-negative thymocytes with a productive rearrangement of the TCR-beta locus are selected to continue maturation to the CD4+8+ double-positive stage, driven by signals through the pre-TCR. The signals through the pre-TCR can be synchronized by injection of mice with anti-CD3 epsilon monoclonal antibody. Using this approach, we demonstrated coordinated induction of a triad of responses in immature thymocytes: arrest of V to DJ rearrangement in the TCR-beta locus, transient down-regulation of rearrangement-activating gene (RAG)-1 and RAG-2 transcripts, and initiation of germ-line transcription of the TCR-alpha locus. These results suggest that the transition from TCR-beta to TCR-alpha locus rearrangement is controlled by signal transduction through the pre-TCR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774628     DOI: 10.1002/eji.1830250519

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  CD3-epsilon overexpressed in prothymocytes acts as an oncogene.

Authors:  B Wang; J She; M Salio; D Allen; E Lacy; N Lonberg; C Terhorst
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Regulation of T cell receptor (TCR) beta gene expression by CD3 complex signaling in immature thymocytes: implications for TCRbeta allelic exclusion.

Authors:  J Biro; A Würch; A J Potocnik; I Falk; H Mossmann; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody.

Authors:  J Wang; K Lim; A Smolyar; M Teng; J Liu; A G Tse; J Liu; R E Hussey; Y Chishti; C T Thomson; R M Sweet; S G Nathenson; H C Chang; J C Sacchettini; E L Reinherz
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

4.  Tcra enhancer activation by inducible transcription factors downstream of pre-TCR signaling.

Authors:  Beatriz del Blanco; Alberto García-Mariscal; David L Wiest; Cristina Hernández-Munain
Journal:  J Immunol       Date:  2012-02-22       Impact factor: 5.422

5.  The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages.

Authors:  M C Haks; P Krimpenfort; J Borst; A M Kruisbeek
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Pre-TCR-induced beta-catenin facilitates traversal through beta-selection.

Authors:  Mai Xu; Archna Sharma; David L Wiest; Jyoti Misra Sen
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

7.  Identification of the transgenic integration site in immunodeficient tgε26 human CD3ε transgenic mice.

Authors:  Izumi Ohigashi; Yuki Yamasaki; Tsukasa Hirashima; Yousuke Takahama
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

8.  The requirement for pre-TCR during thymic differentiation enforces a developmental pause that is essential for V-DJβ rearrangement.

Authors:  Karen S Hathcock; Lila Farrington; Irina Ivanova; Ferenc Livak; Roza Selimyan; Ranjan Sen; Joy Williams; Xuguang Tai; Richard J Hodes
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

9.  Essential and partially overlapping role of CD3gamma and CD3delta for development of alphabeta and gammadelta T lymphocytes.

Authors:  B Wang; N Wang; M Salio; A Sharpe; D Allen; J She; C Terhorst
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

10.  Identification of a late stage of small noncycling pTalpha- pre-T cells as immediate precursors of T cell receptor alpha/beta+ thymocytes.

Authors:  C Trigueros; A R Ramiro; Y R Carrasco; V G de Yebenes; J P Albar; M L Toribio
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.